Indirubin is the active ingredient of Danggui Longhui Wan, a mixture of plants that is used in traditional Chinese medicine to treat chronic diseases. Here we identify indirubin and its analogues ...

CDK2 inhibitors have received some attention at the 2024 ESMO Congress, with one candidate, PF-07104091, showing combination potential with CDK4-selective blockade in HR–positive, HER2–negative breast ...

The experiments involving palbociclib do not disentangle cell cycle effects. Adding Cdk4 inhibitors will progressively arrest more and more cells in the G1 phase and so there will be a reduction not ...

The study addresses the complex regulation of HSCs, highlighting p21's multifunctional nature beyond cell cycle control. Through the use of p21-tdTomato mice, researchers differentiate between p21 ...

Patients are preselected for CDKN2A and/or CDKN2B abnormalities -- Safety and efficacy data to be reported at an upcoming oncology medical ...

CAK itself is a member of the Cdk family and functions as a positive regulator of Cdk1, Cdk2, Cdk4, and Cdk6. [1] Cyclin binding alone causes partial ... In all cases, CAK tends to be in constant ...

In this issue, Papismadov et al (2024) report that p21 (CDKN1A), known to activate the senescence growth arrest, also ...

The Cell Division Cycle 7 Related Protein Kinase pipeline drugs market research report outlays comprehensive information on the Cell Division Cycle 7 Related Protein Kinase targeted therapeutics, ...

Details of the presentation are listed below: About Cyclacel Pharmaceuticals, Inc.

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...